Home About us Contact
|
Home About us Contact | ||
|
|
||
European Academy (european + academy)
Selected AbstractsTHE EUROPEAN ACADEMY OF ANAESTHESIOLOGY THE EUROPEAN DIPLOMA IN ANAESTHESIOLOGY AND INTENSIVE CAREACTA ANAESTHESIOLOGICA SCANDINAVICA, Issue 2 2001Article first published online: 18 JUL 200 No abstract is available for this article. [source] European Academy of Childhood Disability Annual Meeting 2002, 24-26th OctoberDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 10 2002Article first published online: 13 FEB 200 First page of article [source] European Academy of Childhood Disability Annual Meeting 2001DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 10 2001Article first published online: 13 FEB 200 First page of article [source] European Academy of Childhood Disability at GöteborgDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 9 2001Article first published online: 13 FEB 200 No abstract is available for this article. [source] Teaching the future teachers in geriatrics: The 10-year success story of the European Academy for Medicine of AgingGERIATRICS & GERONTOLOGY INTERNATIONAL, Issue 2 2005S Bonin-Guillaume While celebrating the 10th anniversary of the European Academy for Medicine of Aging (EAMA), former students and EAMA members identify 10 major factors that led to the success of the EAMA: (i) extremely motivated academic geriatricians anticipating the future care needs of the oldest old Europeans; (ii) EAMA's exclusive goal ,to teach the future teachers in geriatrics'; (iii) an excellent location in Switzerland with outstanding teaching facilities; (iv) a residential course of four 1-week sessions over 2 years consisting of innovative and contemporary content with the strong involvement of the EAMA's scientific board members; (v) a multicultural melting pot of young, promising geriatricians (from 24 different countries) who constitute the academic geriatric relief of tomorrow; (vi) numerous teachers and experts from all over the world; (vii) permanent and informal interaction between students and teachers; (viii) students' evaluations show marked progress in regard to scientific content, formulation of take-home messages and techniques of oral presentation before and after each course (over 90% of the participants of the first four courses were promoted and 20% obtained a full professorship in geriatrics); (ix) the well-designed EAMA concept is confirmed and validated with the recent accreditation by the European Community and the European Union Geriatric Medicine Society; and former students constituting a strong international network have been able to launch similar courses in elsewhere (Middle East Academy for Medicine of Aging; Latin America Academy for Medicine of Aging; Saint Louis University Geriatric Academy; and the European Nursing Academy for the care of the olders). [source] Statutes of the European Academy of AndrologyINTERNATIONAL JOURNAL OF ANDROLOGY, Issue 2001Article first published online: 18 JUL 200 No abstract is available for this article. [source] News from the European Academy of AndrologyINTERNATIONAL JOURNAL OF ANDROLOGY, Issue 6 2000Announcement No abstract is available for this article. [source] News from the European Academy of AndrologyINTERNATIONAL JOURNAL OF ANDROLOGY, Issue 4 2000Article first published online: 4 JAN 200 No abstract is available for this article. [source] News from the European Academy of AndrologyINTERNATIONAL JOURNAL OF ANDROLOGY, Issue 2 2000Article first published online: 24 DEC 200 [source] Sixth European Workshop on Periodontology of the European Academy of Periodontology at the Charterhouse at Ittingen, Thurgau, SwitzerlandJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 2008Niklaus P. Lang [source] Fifth European Workshop on Periodontology (EWP) of the European Academy of Periodontology (EAP), Charterhouse at Ittingen, Thurgau, SwitzerlandJOURNAL OF CLINICAL PERIODONTOLOGY, Issue 2005Niklaus P. Lang [source] Training Civil Servants for Crisis ManagementJOURNAL OF CONTINGENCIES AND CRISIS MANAGEMENT, Issue 4 2000Laurent F. Carrel This article describes and reflects upon actual experiences in training leaders in the Swiss government. Five thematic areas that are fundamental to preparing a government for leadership in a crisis are presented. Additionally, planning the training, the use of expertise and factors which facilitate or hinder strategic learning are discussed. The author recommends the development of a model learning strategy for governments, with the assistance of the European Academy for Crisis Management. [source] Establishing a standardized quality management system for the European Health Network GA2LEN,ALLERGY, Issue 6 2010L. Heinzerling To cite this article: Heinzerling L, Burbach G, van Cauwenberge P, Papageorgiou P, Carlsen K-H, Lřdrup Carlsen KC, Zuberbier T. Establishing a standardized quality management system for the European Health Network GA2LEN. Allergy 2010; 65: 743,752. Abstract Background:, Quality management is increasingly important in clinical practice. The Global Allergy and Asthma European Network (GA2LEN) is a network of clinical and scientific excellence with originally 25 allergy centres in 16 European countries, a scientific society (European Academy of Allergology and Clinical Immunology), and a patient organization (European Federation of Allergy and Airways Diseases Patients' Associations). Although some allergy centres adhere to internal quality criteria, the implementation of a standardized quality management system for allergy centres across Europe was lacking. Objectives:, To implement standardized quality criteria among allergy centres organized within GA2LEN and thus ensure equal standards of diagnosis and care as well as to establish a culture of continuous quality improvement. Methods:, Quality criteria covering, e.g., diagnostic and therapeutic procedures, and emergency preparedness to assure patient safety were developed and agreed upon by all 25 participating centres. To assure implementation of quality criteria, centres were audited to check quality indicators and document deviations. A follow-up survey was used to assess the usefulness of the project. Results:, Deviations were documented mainly in the areas of emergency care/patient safety (27.3% lacked regular emergency training of doctors and nurses; 22.7% inadequate emergency intervention equipment; 22.7% lacked critical incidence reporting/root cause analyses) and handling of extracts/pharmaceuticals (31.8% lacked temperature logs of fridges; 4.5% inadequate check of expiration dates). Quality improvement was initiated as shown by findings of re-audits. Usefulness of the project was rated high. Conclusion:, The establishment of a quality management system with joint standards of care and harmonized procedures can be achieved in an international health network and ensures quality of care. [source] The definition and diagnostic testing of physical and cholinergic urticarias , EAACI/GA2LEN/EDF/UNEV consensus panel recommendationsALLERGY, Issue 12 2009M. Magerl The recommendations for the definition and diagnosis presented in this position paper are the result of a panel consensus meeting held in December 2008 in Berlin. This consensus meeting was a joint initiative of EAACI (European Academy of Allergology and Clinical Immunology) Dermatology Section, the EU-funded network of excellence, GA2LEN (Global Allergy and Asthma European Network), the EDF (European Dermatology Forum) and UNEV (urticaria network e.V.). The aim of these recommendations is to improve the diagnosis and management of patients with physical urticaria or cholinergic urticaria and to promote research and a better understanding of these diseases. Our recommendations used the paper produced by a 1996 expert meeting (1) and they acknowledge the latest changes in our understanding of physical urticarias and cholinergic urticaria as well as the recent development of novel diagnostic tools. In addition, this consensus paper highlights areas of need for further research. [source] EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticariaALLERGY, Issue 10 2009T. Zuberbier This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA˛LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 64:1427,1443] is the result of a consensus reached during a panel discussion at the 3rd International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA˛LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO). Urticaria is a frequent disease. The life-time prevalence for any subtype of urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors, and pathomechanisms. In addition, it outlines evidence-based diagnostic approaches for different subtypes of urticaria. The correct management of urticaria, which is of paramount importance for patients, is very complex and is consequently covered in a separate guideline developed during the same consensus meeting. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). [source] EAACI/GA˛LEN/EDF/WAO guideline: management of urticariaALLERGY, Issue 10 2009T. Zuberbier This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA˛LEN/EDF/WAO Guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64: 1417,1426), is the result of a consensus reached during a panel discussion at the Third International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA˛LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO). As members of the panel, the authors had prepared their suggestions regarding management of urticaria before the meeting. The draft of the guideline took into account all available evidence in the literature (including Medline and Embase searches and hand searches of abstracts at international allergy congresses in 2004,2008) and was based on the existing consensus reports of the first and the second symposia in 2000 and 2004. These suggestions were then discussed in detail among the panel members and with the over 200 international specialists of the meeting to achieve a consensus using a simple voting system where appropriate. Urticaria has a profound impact on the quality of life and effective treatment is, therefore, required. The recommended first line treatment is new generation, nonsedating H1 -antihistamines. If standard dosing is not effective, increasing the dosage up to four-fold is recommended. For patients who do not respond to a four-fold increase in dosage of nonsedating H1 -antihistamines, it is recommended that second-line therapies should be added to the antihistamine treatment. In the choice of second-line treatment, both their costs and risk/benefit profiles are most important to consider. Corticosteroids are not recommended for long-term treatment due to their unavoidable severe adverse effects. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS). [source] Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy)ALLERGY, Issue 8 2008L. B. Schwartz Exercise-induced (EI) hypersensitivity disorders are significant problems for both recreational and competitive athletes. These include EI-asthma, EI-bronchoconstriction, EI-rhinitis, EI-anaphylaxis and EI,urticaria. A group of experts from the European Academy of Allergology and Clinical Immunology and the American Academy of Allergy Asthma and Immunology met to discuss the pathogenesis of these disorders and how to diagnose and treat them, and then to develop a consensus report. Key words (exercise with asthma, bronchoconstriction, rhinitis, urticaria or anaphylaxis) were used to search Medline, the Cochrane database and related websites through February 2008 to obtain pertinent information which, along with personal reference databases and institutional experience with these disorders, were used to develop this report. The goal is to provide physicians with guidance in the diagnosis, understanding and management of EI-hypersensitivity disorders to enable their patients to safely return to exercise-related activities. [source] Immunology highlights at high altitude: review of the fourth EAACI-GA2LEN Davos MeetingALLERGY, Issue 10 2006J. Gutermuth The field of allergy is moving fast. To keep pace with the underlying immunologic mechanisms, the 4th EAACI-GA2LEN Davos meeting on ,Basic Immunology Research in Allergy and Clinical Immunology' was organized in Grainau, Germany, February 16th,19th, 2006 by the Immunology Section of the European Academy of Allergy and Clinical Immunology and the ZAUM , Center for Allergy and Environment, Technical University Munich, with generous support from GA2LEN. Recent advances and new insights on innate and adaptive immunity, environmental factors influencing immune responses, immune regulation and allergic inflammation were presented by keynote speakers and selected participants. [source] Diagnosis of nonimmediate reactions to ,-lactam antibioticsALLERGY, Issue 11 2004A. Romano Nonimmediate manifestations (i.e. occurring more than 1 h after drug administration), particularly maculopapular and urticarial eruptions, are common during , -lactam treatment. The mechanisms involved in most nonimmediate reactions seem to be heterogeneous and are not yet completely understood. However, clinical and immunohistological studies, as well as analysis of drug-specific T-cell clones obtained from the circulating blood and the skin, suggest that a type-IV (cell-mediated) pathogenic mechanism may be involved in some nonimmediate reactions such as maculopapular or bullous rashes and acute generalized exanthematous pustulosis. In the diagnostic work-up, the patient's history is fundamental; patch testing is useful, together with delayed-reading intradermal testing. The latter appears to be somewhat more sensitive than patch testing, but also less specific. In case of negative allergologic tests, consideration should be given to provocation tests, and the careful administration of the suspect agents. With regard to in vitro tests, the lymphocyte transformation test may contribute to the identification of the responsible drug. Under the aegis of the European Academy of Allergology and Clinical Immunology (EAACI) interest group on drug hypersensitivity and the European Network for Drug Allergy (ENDA), in this review we describe the general guidelines for evaluating subjects with nonimmediate reactions to , -lactams. [source] Dietary prevention of allergic diseases in infants and small childrenPEDIATRIC ALLERGY AND IMMUNOLOGY, Issue 1 2008Amendment to previous published articles in Pediatric Allergy, Clinical Immunology, European Academy of Allergology, Immunology 200, by an expert group set up by the Section on Pediatrics Because of scientific fraud four trials have been excluded from the original Cochrane meta-analysis on formulas containing hydrolyzed protein for prevention of allergy and food intolerance in infants. Unlike the conclusions of the revised Cochrane review the export group set up by the Section on Paediatrics, European Academy of Allergology and Clinical Immunology (SP-EAACI) do not find that the exclusion of the four trials demands a change of the previous recommendations regarding primary dietary prevention of allergic diseases. Ideally, recommendations on primary dietary prevention should be based only on the results of randomized and quasi-randomized trials (selection criteria in the Cochrane review). However, regarding breastfeeding randomization is unethical, Therefore, in the development of recommendations on dietary primary prevention, high-quality systematic reviews of high-quality cohort studies should be included in the evidence base. The study type combined with assessment of the methodological quality determines the level of evidence. In view of some methodological concerns in the Cochrane meta-analysis, particularly regarding definitions and diagnostic criteria for outcome measures and inclusion of non peer-reviewed studies/reports, a revision of the Cochrane analysis may seem warranted. Based on analysis of published peer-reviewed observational and interventional studies the results still indicate that breastfeeding is highly recommended for all infants irrespective of atopic heredity. A dietary regimen is effective in the prevention of allergic diseases in high-risk infants, particularly in early infancy regarding food allergy and eczema. The most effective dietary regimen is exclusively breastfeeding for at least 4,6 months or, in absence of breast milk, formulas with documented reduced allergenicity for at least the first 4 months, combined with avoidance of solid food and cow's milk for the first 4 months. [source] Allergy and Pediatric Allergy and Immunology are the official organs of the European Academy of Allergology and Clinical ImmunologyPEDIATRIC ALLERGY AND IMMUNOLOGY, Issue 6 2004J. O. Warner First page of article [source] European Academy of Paediatrics Research in Ambulatory Setting network (EAPRASnet): a multi-national general paediatric research network for better child healthCHILD: CARE, HEALTH AND DEVELOPMENT, Issue 3 2010S. Del Torso Abstract Background In 2008, the European Academy of Paediatrics launched a paediatric-based research network , EAPRASnet (European Academy of Paediatrics Research in Ambulatory Setting network). The network has recruited primary care and general paediatricians from European and Mediterranean countries. Methods Every paediatrician joining the network has been asked to complete a recruitment survey. The aims of the survey were to characterize paediatrician's demographics, practice arrangements and patient's demographics, to define main incentives for research, and to learn what paediatricians view as unsolved issues that need to be studied. Results A total of 156 paediatricians from 19 countries were recruited with 144 completing the questionnaire (92%). Majority of respondents (89%) were general paediatricians for more than half of their time. Practice arrangement of 47% of paediatricians was solo practice, with 40% in group practice. Electronic medical records were being used by 72% of respondents. Over 70% of the paediatricians had more than 1000 patients under their clinical care, and patients younger than 6 years old contributed nearly half of the patient population. Areas of most interest for research were: quality of care indicators, communication with parents, obesity, attention deficit hyperactivity disorder and effective well child care. Main incentives for participation in a research project were interest in the topic (81%) and effort to improve quality of care (71%). Lack of time was the leading reported obstacle for research activity (72%). EAPRASnet is growing, and the network's structure, operation and funding are described. Methods for joining the network and the process of study development are presented. Conclusion A core group of EAP general paediatricians are committed to research in their practices. The information gathered will serve for future planning of research projects in the EAPRASnet to harmonize and optimize the care given to children in the primary care setting in Europe. [source] | ||||||||||